Nov 21, 2025 · In May 2024, the FDA approved the first generic versions of Entresto. But they couldn’t be brought to market until the brand-name version’s patent expired. The first Entresto generic …

Nov 13, 2025 · Wondering when a generic version of Entresto will be available? Get details on FDA approval status, generic manufacturers, and patent expirations.

Nov 4, 2025 · Yes, generic Entresto is now available. Entresto generics, sold simply as sacubitril-valsartan tablets, were approved in May 2024 but only hit U.S. pharmacy shelves in July 2025.

Aug 5, 2025 · Generic Entresto (sacubitril/valsartan) has recently been approved by the FDA and released in 24mg/26mg, 49mg/51mg and 97mg/103mg dosage tablets.

Nov 22, 2025 · Following years of legal disputes, generic versions of the heart failure medication Entresto (sacubitril/valsartan) became commercially available in mid-2025, offering a significantly …

2 days ago · A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto.

Jul 11, 2025 · Novartis told the court in a separate filing on Friday that India-based MSN may receive U.S. Food and Drug Administration approval for the generic as soon as July 16 and launch it soon after.

Entresto® (sacubitril/valsartan) – First-time generic July 22, 2025 - Novadoz launched MSN’s AB-rated generic version of Novartis’ Entresto (sacubitril/valsartan) tablets.

Aug 15, 2025 · The overall assessment suggests that while generic entry for certain formulations may begin in 2025 after key patent expirations, comprehensive market entry will be challenging until the …

Jul 11, 2025 · A US federal judge on Friday rejected Novartis' efforts to block the launch of a generic version of its blockbuster cardiovascular (CV) disease drug, opening the door for competition to arrive …